AR065176A1 - Poliformos de acido [ 1 - ( 4 - terc - butil -bencil ) - 5 - ( 3 - metilfenil ) - 1 h - indol - 3 - i l ) ( oxo ) acetico ; composiciones farmaceuticas y mezclas que lo comprenden; metodos para preparar los polimoformos, tratar trombosis o deterioro fibrinolitico, isquemia miocardica, enfermedad de - Google Patents

Poliformos de acido [ 1 - ( 4 - terc - butil -bencil ) - 5 - ( 3 - metilfenil ) - 1 h - indol - 3 - i l ) ( oxo ) acetico ; composiciones farmaceuticas y mezclas que lo comprenden; metodos para preparar los polimoformos, tratar trombosis o deterioro fibrinolitico, isquemia miocardica, enfermedad de

Info

Publication number
AR065176A1
AR065176A1 ARP080100473A ARP080100473A AR065176A1 AR 065176 A1 AR065176 A1 AR 065176A1 AR P080100473 A ARP080100473 A AR P080100473A AR P080100473 A ARP080100473 A AR P080100473A AR 065176 A1 AR065176 A1 AR 065176A1
Authority
AR
Argentina
Prior art keywords
oxo
polymophorms
polyforms
methylpenyl
bencil
Prior art date
Application number
ARP080100473A
Other languages
English (en)
Inventor
Hsueh-Ling Wu
Abdolsamad Tadayon
Mannching Sherry Ku
David Zenan Li
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR065176A1 publication Critical patent/AR065176A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicacion 1: Un polimorfo (Forma A) de ácido [1-(4-terc-Butilbencil)-5-(3-metilfenil)-1H-indol-3- il](oxo)acético, caracterizado porque tiene un patron de difraccion de rayos X en polvo que comprende picos característicos, en términos de 2theta, en 6.5° y 10.9°.
ARP080100473A 2007-02-05 2008-02-05 Poliformos de acido [ 1 - ( 4 - terc - butil -bencil ) - 5 - ( 3 - metilfenil ) - 1 h - indol - 3 - i l ) ( oxo ) acetico ; composiciones farmaceuticas y mezclas que lo comprenden; metodos para preparar los polimoformos, tratar trombosis o deterioro fibrinolitico, isquemia miocardica, enfermedad de AR065176A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89947307P 2007-02-05 2007-02-05

Publications (1)

Publication Number Publication Date
AR065176A1 true AR065176A1 (es) 2009-05-20

Family

ID=39676711

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100473A AR065176A1 (es) 2007-02-05 2008-02-05 Poliformos de acido [ 1 - ( 4 - terc - butil -bencil ) - 5 - ( 3 - metilfenil ) - 1 h - indol - 3 - i l ) ( oxo ) acetico ; composiciones farmaceuticas y mezclas que lo comprenden; metodos para preparar los polimoformos, tratar trombosis o deterioro fibrinolitico, isquemia miocardica, enfermedad de

Country Status (8)

Country Link
US (1) US20080188542A1 (es)
EP (1) EP2061757A2 (es)
AR (1) AR065176A1 (es)
CL (1) CL2008000354A1 (es)
PA (1) PA8768801A1 (es)
PE (1) PE20081757A1 (es)
TW (1) TW200840564A (es)
WO (1) WO2008097938A2 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1397130B1 (en) * 2001-06-20 2007-07-25 Wyeth Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)

Also Published As

Publication number Publication date
PE20081757A1 (es) 2009-01-21
EP2061757A2 (en) 2009-05-27
WO2008097938A3 (en) 2009-09-11
US20080188542A1 (en) 2008-08-07
WO2008097938A2 (en) 2008-08-14
CL2008000354A1 (es) 2008-03-14
TW200840564A (en) 2008-10-16
PA8768801A1 (es) 2009-02-09

Similar Documents

Publication Publication Date Title
CL2007003226A1 (es) Compuestos derivados de piridinona; composicion farmaceutica; y uso para tratar el cancer.
EA200870385A1 (ru) Ингибирование токсичности альфа-синуклеина
EA201070786A1 (ru) Бензофуропиримидиноны
PA8660001A1 (es) Amino-imidazolonas para la inhibicion de b-secretasa
UY28745A1 (es) Nuevos compuestos
BRPI0922364A2 (pt) Composto, composição farmacêutica e uso de um composto
CL2012000315A1 (es) Compuestos derivados de heterociclos; y proceso de aplicacion de dichos compuestos.
BRPI0515499A (pt) derivados de piridina para a inibição de estearoil-coa-desaturase humana
UY30082A1 (es) Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
CO6390081A2 (es) Compuestos organicos
CL2007002916A1 (es) Compuestos derivados de pirazoliltienopiridinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en la inhibicion de escaras.
IL186400A0 (en) Compositions and methods for the inhibition of dishevelled proteins
FI20065775A0 (sv) Lagring av verktyg i krossanordning
CL2008000029A1 (es) Compuestos derivados de 1-bencil imidazol, inhibidores de eg-5; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
MX2010004897A (es) Forma de dosificacion oralmente desintegrada.
CL2007002034A1 (es) Compuestos derivados de hidroximoil-tetrazol; composicion fungicida que comprende dichos compuestos uso del compuesto o la composicion para controlar de forma curativa o preventiva los hongos fitopatogenos de las plantas o cultivos;y metodo para controlar hongos pitopatogenos de plantas o cultivos.
CL2007001630A1 (es) Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
WO2007034279A3 (en) C3a antagonists and pharmaceutical compositions thereof
CR10722A (es) Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintetasa quinasa 3
AR059913A1 (es) Cristales modificados de (5s)-5-[4-(5cloropiridin-2-iloxi)piperidina-1-sulfonilmetil]-5-metilimidazolidina-2,4 diona. procesos de obtencion y composiciones farmaceuticas.
CU20190029A7 (es) Compuestos de aza-indazol útiles en lesiones de tendones y/o ligamentos
PA8630801A1 (es) Nuevos imidazoles
ATE400718T1 (de) Schliesszylinder
AR063027A1 (es) Derivados de sulfonamida
AR065565A1 (es) Formas solidas de 1-metil-5-(2-(5-(trifluoro-metil)-1h-imidazol-2-il)-piridin-4-iloxi)-n-(4-(trifluoro-metil)-fenil)-1h-benzo-[d]-imidazol-2-amina con actividad inhibidora de cinasa raf y una composicion farmaceutica que las comprende.

Legal Events

Date Code Title Description
FB Suspension of granting procedure